International Journal of Molecular Medical Science, 2024, Vol.14, No.4, 252-263 http://medscipublisher.com/index.php/ijmms 261 Banik A., Brown R., Bamburg J., Lahiri D., Khurana D., Friedland R., Chen W., Ding Y., Mudher A., Padjen A., Mukaetova-Ladinska E., Ihara M., Srivastava S., Srivastava M., Masters C., Kalaria R., and Anand A., 2015, Translation of pre-clinical studies into successful clinical trials for Alzheimer's disease: what are the roadblocks and how can they be overcome?, Journal of Alzheimer's Disease, 47(4): 815-843. https://doi.org/10.3233/JAD-150136 PMid:26401762 Barman N., Khan N., Islam M., Nain Z., Roy R., Haque A., and Barman S., 2020, CRISPR-Cas9: a promising genome editing therapeutic tool for Alzheimer's disease-a narrative review, Neurology and Therapy, 9: 419-434. https://doi.org/10.1007/s40120-020-00218-z PMid:33089409 PMCid:PMC7606404 Bhardwaj S., Kesari K., Rachamalla M., Mani S., Ashraf G., Jha S., Kumar P., Ambasta R., Dureja H., Devkota H., Gupta G., Chellappan D., Singh S., Dua K., Ruokolainen J., Kamal M., Ojha S., and Jha N., 2021, CRISPR/Cas9 gene editing: new hope for Alzheimer's disease therapeutics, Journal of Advanced Research, 40: 207-221. https://doi.org/10.1016/j.jare.2021.07.001 PMid:36100328 PMCid:PMC9481950 Breijyeh Z., and Karaman R., 2020, Comprehensive review on Alzheimer's disease: causes and treatment, Molecules, 25(24): 5789. https://doi.org/10.3390/molecules25245789 PMid:33302541 PMCid:PMC7764106 Butt M., Zaman M., Ahmad A., Khan R., Mallhi T., Hasan M., Khan Y., Hafeez S., Massoud E., Rahman M., and Cavalu S., 2022, Appraisal for the potential of viral and nonviral vectors in gene therapy: a review, Genes, 13(8): 1370. https://doi.org/10.3390/genes13081370 PMid:36011281 PMCid:PMC9407213 Castle M., Baltanás F., Kovács I., Nagahara A., Barba D., and Tuszynski M., 2020, Postmortem analysis in a clinical trial of AAV2-NGF gene therapy for alzheimer's disease identifies a need for improved vector delivery, Human Gene Therapy, 31(7-8): 415-422. https://doi.org/10.1089/hum.2019.367 PMid:32126838 PMCid:PMC7194314 Chen W., Hu Y., and Ju D., 2020, Gene therapy for neurodegenerative disorders: advances, insights and prospects, Acta Pharmaceutica Sinica B, 10: 1347-1359. https://doi.org/10.1016/j.apsb.2020.01.015 PMid:32963936 PMCid:PMC7488363 Congdon E., and Sigurdsson E., 2018, Tau-targeting therapies for Alzheimer disease, Nature Reviews Neurology, 14: 399-415. https://doi.org/10.1038/s41582-018-0013-z PMid:29895964 PMCid:PMC6463489 Costa-Laparra I., Juárez-Escoto E., Vicario C., Moratalla R., and García-Sanz P., 2023, APOE ε4 allele, along with G206D-PSEN1 mutation, alters mitochondrial networks and their degradation in Alzheimer's disease, Frontiers in Aging Neuroscience, 15: 1087072. https://doi.org/10.3389/fnagi.2023.1087072 PMid:37455931 PMCid:PMC10340123 Davis D., 2017, Ethical issues in Alzheimer's disease research involving human subjects, Journal of Medical Ethics, 43: 852-856. https://doi.org/10.1136/medethics-2016-103392 PMid:28798225 Ediriweera G., Chen L., Yerbury J., Thurecht K., and Vine K., 2021, Non-viral vector-mediated gene therapy for ALS: challenges and future perspectives, Molecular Pharmaceutics, 18(6): 2142-2160. https://doi.org/10.1021/acs.molpharmaceut.1c00297 PMid:34010004 Gao Y., Ren R., Zhong Z., Dammer E., Zhao Q., Shan S., Zhou Z., Li X., Zhang Y., Cui H., Hu Y., Chen S., Chen J., Guo Q., and Wang G., 2019, Mutation profile of APP, PSEN1, and PSEN2 in Chinese familial Alzheimer's disease, Neurobiology of Aging, 77: 154-157. https://doi.org/10.1016/j.neurobiolaging.2019.01.018 PMid:30822634 Ghaffari M., Sanadgol N., and Abdollahi M., 2020, A systematic review of current progresses in the nucleic acid-based therapies for neurodegeneration with Implications for Alzheimer's disease, Mini Reviews in Medicinal Chemistry, 20(15): 1499-1517. https://doi.org/10.2174/1389557520666200513122357 PMid:32400332 Giau V., Bagyinszky E., Youn Y., An S., and Kim S., 2019, APP, PSEN1, and PSEN2 mutations in Asian patients with early-onset Alzheimer disease, International Journal of Molecular Sciences, 20(19): 4757. https://doi.org/10.3390/ijms20194757 PMid:31557888 PMCid:PMC6801447 Guven G., Samancı B., Gulec C., Hanagasi H., Gurvit H., Gokalp E., Tepgec F., Guler S., Uyguner O., and Bilgiç B., 2021, A novel PSEN2 p.Ser175Phe variant in a family with Alzheimer's disease, Neurological Sciences, 42: 2497-2504. https://doi.org/10.1007/s10072-021-05243-w PMid:33855622
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==